Maxeon Solar Technologies Announces First Quarter 2023 Financial Results
--
--2023 Adjusted EBITDA Guidance Increased to
Maxeon's Chief Executive Officer Bill Mulligan noted, "Maxeon delivered strong financial performance in Q1, executing well across the organization and exceeding our gross margin and Adjusted EBITDA targets. Our DG business benefited from prudent supply chain management and solid ASP execution in
Mulligan continued, "While our team is energized by delivering a strong start to the year, we remain highly focused on executing our strategy and achieving our full year 2023 financial targets. With Q1 results exceeding our expectations we are raising our 2023 Adjusted EBITDA guidance from
Selected Q1 Unaudited Financial Summary
(In thousands, except shipments) | Fiscal Q1 2023 | Fiscal Q4 2022 | Fiscal Q1 2022 | ||
Shipments, in MW | 774 | 734 | 488 | ||
Revenue | $ 318,332 | $ 323,503 | $ 223,081 | ||
Gross profit (loss)(1) | 53,625 | 20,087 | (12,964) | ||
GAAP Operating expenses | 41,921 | 38,038 | 37,410 | ||
GAAP Net income (loss) attributable to the stockholders(1) | 20,271 | (75,701) | (59,112) | ||
Capital expenditures | 16,500 | 7,314 | 21,682 | ||
Other Financial Data(1), (2) | |||||
(In thousands) | Fiscal Q1 2023 | Fiscal Q4 2022 | Fiscal Q1 2022 | ||
Non-GAAP Gross profit (loss) | $ 54,142 | $ 20,696 | $ (12,542) | ||
Non-GAAP Operating expenses | 38,056 | 34,488 | 34,367 | ||
Adjusted EBITDA | 30,984 | (3,712) | (33,590) |
(1) | The Company's GAAP and Non-GAAP results were impacted by the effects of certain items. Refer to "Supplementary information affecting GAAP and Non-GAAP results" below. |
(2) | The Company's use of Non-GAAP financial information, including a reconciliation to |
Supplementary information affecting GAAP and Non-GAAP results
Three Months Ended | ||||||
(In thousands) | Financial | April 2, 2023 | January 1, 2023 | April 3, 2022 | ||
Incremental cost of above market polysilicon(1) | Cost of revenue | 237 | 30 | 7,388 | ||
Loss on ancillary sales of excess polysilicon(2), (3) | Cost of revenue | — | — | 8,328 |
(1) | Relates to the difference between our contractual cost for the polysilicon under the long-term fixed supply agreements with our supplier and the price of polysilicon available in the market as derived from publicly available information at the beginning of each quarter, multiplied by the volume of modules sold within the quarter. |
(2) | In order to reduce inventory and improve working capital, we had periodically elected to sell polysilicon inventory procured under the long-term fixed supply agreements in the market at prices below our purchase price, thereby incurring a loss. There was no such sale in the three months ended April 2, 2023 and January 1, 2023. |
(3) | For the three months ended April 3, 2022, the loss on ancillary sales of excess polysilicon also included |
Fiscal Year 2023 and Second Quarter 2023 Outlook
For the second quarter of 2023, the Company anticipates the following results:
(In millions, except shipments) | Outlook |
Shipments, in MW | 860 - 900 |
Revenue | |
Gross profit | |
Non-GAAP gross profit(1) | |
Operating expenses | |
Non-GAAP operating expenses(2) | |
Adjusted EBITDA(3) | |
Capital expenditures(4) |
For fiscal year 2023, the Company anticipates the following revised results:
– Revenue to be within a range of
– Adjusted EBITDA to be within a range of
(1) | The Company's Non-GAAP gross profit is impacted by the effects of adjusting for stock-based compensation expense. |
(2) | The Company's Non-GAAP operating expenses are impacted by the effects of adjusting for stock-based compensation expense and restructuring charges and fees. |
(3) | The Company cannot provide a reconciliation between its Adjusted EBITDA projection and the most directly comparable GAAP measures without unreasonable efforts because it is unable to predict with reasonable certainty the ultimate outcome of the remeasurement gain or loss of the prepaid forward and the equity in gain or loss of unconsolidated investees. |
(4) | Capital expenditures are directed mainly to preparation for capacity expansion for our Maxeon 7 technology, completion of manufacturing capacity for Performance line panels to be sold in the U.S. market, completion of manufacturing capacity for our Maxeon 6 product platform, further developing Maxeon 7 technology and operating a pilot line, as well as various corporate initiatives. The above excludes capital expenditures in connection to the investment plan to deploy a multi-GW factory in |
These anticipated results for the second quarter of 2023 are preliminary, unaudited and represent the most current information available to management. The Company's business outlook is based on management's current views and estimates with respect to market conditions, production capacity and the global economic environment. Please refer to Forward Looking Statements section below. Management's views and estimates are subject to change without notice.
For more information
Maxeon's first quarter 2023 financial results and management commentary can be found on Form 6-K by accessing the Financials & Filings page of the Investor Relations section of Maxeon's website at: https://corp.maxeon.com/investor-relations. The Form 6-K and Company's other filings are also available online from the Securities and Exchange Commission at www.sec.gov.
Conference Call Details
The Company will hold a conference call on May 10, 2023, at 5:00 PM
To join the live conference call, participants must first register here, where a dial-in number will be provided.
A simultaneous audio-only webcast of the conference call will be available on Maxeon's website at https://corp.maxeon.com/events-and-presentations. A webcast replay will be available on Maxeon's website for one year at https://corp.maxeon.com/events-and-presentations.
About Maxeon Solar Technologies
Maxeon Solar Technologies Ltd (NASDAQ: MAXN) is Powering Positive Change™. Headquartered in
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements regarding: (a) our expectations regarding pricing trends, demand and growth projections; (b) potential disruptions to our operations and supply chain that may result from epidemics, natural disasters or military conflicts, including the duration, scope and impact on the demand for our products, market disruptions from the war in , our ability to complete an equity or debt offering or financing at favorable terms, if at all, and our overall liquidity, substantial indebtedness and ability to obtain additional financing; (f) our technology outlook, including anticipated fab capacity expansion and utilization and expected ramp and production timelines for the Company's Maxeon 6, next-generation Maxeon 7 and Performance line solar panels, expected cost reductions, and future performance; (g) our strategic goals and plans, including capacity expansion, partnership discussions with respect to the Company's next-generation technology, and our relationships with existing customers, suppliers and partners, and our ability to achieve and maintain them; (h) our expectations regarding our future performance and revenues resulting from contracted orders, bookings, backlog, and pipelines in our sales channels and feedback from our partners; (i) our projected effective tax rate and changes to the valuation allowance related to our deferred tax assets; and (j) our 2023 revenue and adjusted EBITDA guidance and our second quarter fiscal year 2023 guidance, including shipments, revenue, gross profit, non-GAAP gross profit, operating expenses, non-GAAP operating expenses, Adjusted EBITDA, capital expenditures, and related assumptions.
The forward-looking statements can be also identified by terminology such as "may," "might," "could," "will," "aims," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and Maxeon's operations and business outlook contain forward-looking statements.
These forward-looking statements are based on our current assumptions, expectations and beliefs and involve substantial risks and uncertainties that may cause results, performance or achievement to materially differ from those expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to a number of risks. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. Factors that could cause or contribute to such differences include, but are not limited to: (1) challenges in executing transactions key to our strategic plans, including regulatory and other challenges that may arise; (2) our liquidity, substantial indebtedness, terms and conditions upon which our indebtedness is incurred, and ability to obtain additional financing for our projects, customers and operations; (3) our ability to manage supply chain shortages and cost increases and operating expenses; (4) potential disruptions to our operations and supply chain that may result from damage or destruction of facilities operated by our suppliers, difficulties in hiring or retaining key personnel, epidemics, natural disasters, including impacts of the war in
Use of Non-GAAP Financial Measures
We present certain non-GAAP measures such as non-GAAP gross profit (loss), non-GAAP operating expenses and earnings before interest, taxes, depreciation and amortization ("EBITDA") adjusted for stock-based compensation, restructuring charges and fees, remeasurement loss on prepaid forward and physical delivery forward and equity in losses of unconsolidated investees ("Adjusted EBITDA") to supplement our consolidated financial results presented in accordance with GAAP. Non-GAAP gross profit (loss) is defined as gross profit (loss) excluding stock-based compensation. Non-GAAP operating expenses is defined as operating expenses excluding stock-based compensation and restructuring charges and fees.
We believe that non-GAAP gross profit (loss), non-GAAP operating expenses and Adjusted EBITDA provide greater transparency into management's view and assessment of the Company's ongoing operating performance by removing items management believes are not representative of our continuing operations and may distort our longer-term operating trends. We believe these measures are useful to help enhance the comparability of our results of operations across different reporting periods on a consistent basis and with our competitors, distinct from items that are infrequent or not associated with the Company's core operations as presented above. We also use these non-GAAP measures internally to assess our business, financial performance and current and historical results, as well as for strategic decision-making and forecasting future results. Given our use of non-GAAP measures, we believe that these measures may be important to investors in understanding our operating results as seen through the eyes of management. These non-GAAP measures are neither prepared in accordance with GAAP nor are they intended to be a replacement for GAAP financial data, should be reviewed together with GAAP measures and may be different from non-GAAP measures used by other companies.
As presented in the "Reconciliation of Non-GAAP Financial Measures" section, each of the non-GAAP financial measures excludes one or more of the following items in arriving to the non-GAAP measures:
- Stock-based compensation expense. Stock-based compensation relates primarily to equity incentive awards. Stock-based compensation is a non-cash expense that is dependent on market forces that are difficult to predict and is excluded from non-GAAP gross profit (loss), non-GAAP operating expense and Adjusted EBITDA. Management believes that this adjustment for stock-based compensation expense provides investors with a basis to measure our core performance, including the ability to compare our performance with the performance of other companies, without the period-to-period variability created by stock-based compensation.
- Restructuring (benefits) charges and fees. We incur restructuring (benefits) charges and fees related to reorganization plans aimed towards realigning resources consistent with our global strategy and improving its overall operating efficiency and cost structure. Restructuring charges and fees are excluded from non-GAAP operating expenses and Adjusted EBITDA because they are not considered core operating activities. Although we have engaged in restructuring activities and initiatives, past activities have been discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude restructuring charges and fees from our non-GAAP financial measures as they are not reflective of ongoing operating results nor do these charges contribute to a meaningful evaluation of our past operating performance.
- Remeasurement (gain) loss on prepaid forward and physical delivery forward. This relates to the mark-to-market fair value remeasurement of privately negotiated prepaid forward and physical delivery transactions. The transactions were entered into in connection with the issuance on July 17, 2020 of the
6.50% Green Convertible Senior Notes due 2025 for an aggregate principal amount of . The prepaid forward is remeasured to fair value at the end of each reporting period, with changes in fair value booked in earnings. The fair value of the prepaid forward is primarily affected by the Company's share price. The physical delivery forward was remeasured to fair value at the end of the Note Valuation Period on September 29, 2020, and was reclassified to equity after remeasurement, and will not be subsequently remeasured. The fair value of the physical delivery forward was primarily affected by the Company's share price. The remeasurement loss on prepaid forward and physical delivery forward is excluded from Adjusted EBITDA because it is not considered core operating activities. As such, management believes that it is appropriate to exclude the mark-to-market adjustments from our Adjusted EBITDA as it is not reflective of ongoing operating results nor do the loss contribute to a meaningful evaluation of our past operating performance.$200 million - Equity in losses (income) of unconsolidated investees and related gains. This relates to the loss (income) on our unconsolidated equity investment Huansheng JV and gains on such investment. This is excluded from our Adjusted EBITDA financial measure as it is non-cash in nature and not reflective of our core operational performance. As such, management believes that it is appropriate to exclude such charges as they do not contribute to a meaningful evaluation of our performance.
Reconciliation of Non-GAAP Financial Measures | |||||
Three Months Ended | |||||
(In thousands) | April 2, 2023 | January 1, 2023 | April 3, 2022 | ||
Gross profit (loss) | $ 53,625 | $ 20,087 | $ (12,964) | ||
Stock-based compensation | 517 | 609 | 422 | ||
Non-GAAP Gross profit (loss) | 54,142 | 20,696 | (12,542) | ||
GAAP Operating expenses | 41,921 | 38,038 | 37,410 | ||
Stock-based compensation | (4,144) | (2,956) | (2,275) | ||
Restructuring benefits (charges and fees) | 279 | (594) | (768) | ||
Non-GAAP Operating expenses | 38,056 | 34,488 | 34,367 | ||
GAAP Net income (loss) attributable to the stockholders | 20,271 | (75,701) | (59,112) | ||
Interest expense, net | 8,999 | 9,307 | 4,786 | ||
Provision for income taxes | 5,984 | 28,030 | 825 | ||
Depreciation | 14,383 | 14,422 | 12,898 | ||
Amortization | 68 | 57 | 90 | ||
EBITDA | 49,705 | (23,885) | (40,513) | ||
Stock-based compensation | 4,661 | 3,565 | 2,697 | ||
Restructuring (benefits) charges and fees | (279) | 594 | 768 | ||
Remeasurement (gain) loss on prepaid forward | (23,849) | 17,726 | 397 | ||
Equity in losses (income) of unconsolidated investees and related gain | 746 | (1,712) | 3,061 | ||
Adjusted EBITDA | 30,984 | (3,712) | (33,590) |
Reconciliation of Non-GAAP Outlook | |
(In millions) | Outlook |
Gross profit | |
Stock-based compensation | 1 |
Non-GAAP gross profit | |
Operating expenses | |
Stock-based compensation | (5) |
Non-GAAP operating expenses |
©2023 Maxeon Solar Technologies, Ltd. All rights reserved. MAXEON is a registered trademark of Maxeon Solar Technologies, Ltd. Visit https://corp.maxeon.com/trademarks for more information.
MAXEON SOLAR TECHNOLOGIES, LTD. CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (In thousands, except for shares data) | |||
As of | |||
April 2, 2023 | January 1, 2023 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ 278,849 | $ 227,442 | |
Short-term securities | — | 76,000 | |
Restricted short-term marketable securities | 1,008 | 968 | |
Accounts receivable, net | 72,205 | 54,301 | |
Inventories | 316,444 | 303,230 | |
Advances to suppliers, current portion | 1,407 | 2,137 | |
Prepaid expenses and other current assets | 111,046 | 126,971 | |
Total current assets | $ 780,959 | $ 791,049 | |
Property, plant and equipment, net | 368,429 | 380,468 | |
Operating lease right of use assets | 23,197 | 17,844 | |
Intangible assets, net | 340 | 291 | |
Deferred tax assets | 10,037 | 10,348 | |
Other long-term assets | 84,573 | 60,418 | |
Total assets | $ 1,267,535 | $ 1,260,418 | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ 214,351 | $ 247,870 | |
Accrued liabilities | 112,355 | 135,157 | |
Contract liabilities, current portion | 220,084 | 139,267 | |
Short-term debt | 50,440 | 50,526 | |
Operating lease liabilities, current portion | 4,833 | 3,412 | |
Total current liabilities | $ 602,063 | $ 576,232 | |
Long-term debt | 1,544 | 1,649 | |
Contract liabilities, net of current portion | 108,249 | 161,678 | |
Operating lease liabilities, net of current portion | 19,830 | 15,603 | |
Convertible debt | 380,314 | 378,610 | |
Deferred tax liabilities | 14,789 | 14,913 | |
Other long-term liabilities | 66,598 | 63,663 | |
Total liabilities | $ 1,193,387 | $ 1,212,348 | |
Commitments and contingencies | |||
Equity: | |||
Common stock, no par value (45,409,811 and 45,033,027 issued and outstanding as of | $ — | $ — | |
Additional paid-in capital | 588,841 | 584,808 | |
Accumulated deficit | (499,992) | (520,263) | |
Accumulated other comprehensive loss | (20,481) | (22,108) | |
Equity attributable to the Company | 68,368 | 42,437 | |
Noncontrolling interests | 5,780 | 5,633 | |
Total equity | 74,148 | 48,070 | |
Total liabilities and equity | $ 1,267,535 | $ 1,260,418 |
MAXEON SOLAR TECHNOLOGIES, LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (In thousands, except per share data) | ||||
Three Months Ended | ||||
April 2, 2023 | April 3, 2022 | |||
Revenue | $ 318,332 | $ 223,081 | ||
Cost of revenue | 264,707 | 236,045 | ||
Gross profit (loss) | 53,625 | (12,964) | ||
Operating expenses: | ||||
Research and development | 11,076 | 13,894 | ||
Sales, general and administrative | 31,028 | 23,751 | ||
Restructuring benefits | (183) | (235) | ||
Total operating expenses | 41,921 | 37,410 | ||
Operating income (loss) | 11,704 | (50,374) | ||
Other income (expense), net | ||||
Interest expense, net | (8,999) | (4,786) | ||
Other, net | 24,443 | (151) | ||
Other income (expense), net | 15,444 | (4,937) | ||
Income (loss) before income taxes and equity in losses of unconsolidated investees | 27,148 | (55,311) | ||
Provision for income taxes | (5,984) | (825) | ||
Equity in losses of unconsolidated investees | (746) | (3,061) | ||
Net income (loss) | 20,418 | (59,197) | ||
Net (income) loss attributable to noncontrolling interests | (147) | 85 | ||
Net income (loss) attributable to the stockholders | $ 20,271 | $ (59,112) | ||
Net income (loss) per share attributable to stockholders: | ||||
Basic | $ 0.49 | $ (1.45) | ||
Diluted | $ 0.46 | $ (1.45) | ||
Weighted average shares used to compute net income (loss) per share: | ||||
Basic | 41,389 | 40,650 | ||
Diluted | 53,070 | 40,650 |
MAXEON SOLAR TECHNOLOGIES, LTD. CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (unaudited) (In thousands) | |||||||||||||||
Shares | Amount | Additional | Accumulated | Accumulated | Equity | Noncontrolling Interests | Total Equity | ||||||||
Balance at January 1, 2023 | 45,033 | $ — | $ 584,808 | $ (520,263) | $ (22,108) | $ 42,437 | $ 5,633 | $ 48,070 | |||||||
Net income | — | — | — | 20,271 | — | 20,271 | 147 | 20,418 | |||||||
Issuance of common stock for stock-based | 377 | — | — | — | — | — | — | — | |||||||
Recognition of stock-based compensation | — | — | 4,033 | — | — | 4,033 | — | 4,033 | |||||||
Other comprehensive income | — | — | — | — | 1,627 | 1,627 | — | 1,627 | |||||||
Balance at April 2, 2023 | 45,410 | $ — | $ 588,841 | $ (499,992) | $ (20,481) | $ 68,368 | $ 5,780 | $ 74,148 | |||||||
Shares | Amount | Additional | Accumulated | Accumulated | Equity | Noncontrolling | Total Equity | ||||||||
Balance at January 2, 2022 | 44,247 | $ — | $ 624,261 | $ (262,961) | $ (11,844) | $ 349,456 | $ 5,419 | $ 354,875 | |||||||
Effect of adoption of ASU 2020-06 | — | — | (52,189) | 10,122 | — | (42,067) | — | (42,067) | |||||||
Net loss | — | — | — | (59,112) | — | (59,112) | (85) | (59,197) | |||||||
Issuance of common stock for stock-based | 354 | — | (2) | — | — | (2) | — | (2) | |||||||
Distribution to noncontrolling interest | — | — | — | — | — | — | (64) | (64) | |||||||
Recognition of stock-based compensation | — | — | 1,466 | — | — | 1,466 | — | 1,466 | |||||||
Other comprehensive loss | — | — | — | — | (803) | (803) | — | (803) | |||||||
Balance at April 3, 2022 | 44,601 | $ — | $ 573,536 | $ (311,951) | $ (12,647) | $ 248,938 | $ 5,270 | $ 254,208 | |||||||
MAXEON SOLAR TECHNOLOGIES, LTD. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (In thousands) | |||
Three Months Ended | |||
April 2, 2023 | April 3, 2022 | ||
Cash flows from operating activities | |||
Net income (loss) | $ 20,418 | $ (59,197) | |
Adjustments to reconcile net income (loss) to operating cash flows | |||
Depreciation and amortization | 14,451 | 12,988 | |
Stock-based compensation | 4,661 | 2,697 | |
Non-cash interest expense | 2,294 | 1,336 | |
Equity in losses of unconsolidated investees | 746 | 3,061 | |
Deferred income taxes | 188 | 91 | |
Loss on disposal of property, plant and equipment | 9 | 213 | |
Remeasurement (gain) loss on prepaid forward | (23,849) | 397 | |
(Utilization of) provision for excess or obsolete inventories | (10,396) | 1,589 | |
Other, net | (160) | 430 | |
Changes in operating assets and liabilities | |||
Accounts receivable | (17,890) | (12,821) | |
Contract assets | 4 | 532 | |
Inventories | (24,465) | (51,647) | |
Prepaid expenses and other assets | 1,570 | (5,172) | |
Operating lease right-of-use assets | 930 | 627 | |
Advances to suppliers | 730 | 11,043 | |
Accounts payable and other accrued liabilities | (19,312) | 30,344 | |
Contract liabilities | 27,136 | 78,805 | |
Operating lease liabilities | (520) | (631) | |
Net cash (used in) provided by operating activities | (23,455) | 14,685 | |
Cash flows from investing activities | |||
Purchases of property, plant and equipment | (16,500) | (21,682) | |
Purchases of intangible assets | (118) | — | |
Proceeds from maturity of short-term market securities | 76,000 | — | |
Purchase of restricted short-term marketable securities | (10) | — | |
Cash paid for disposal of property, plant and equipment | — | (11) | |
Net cash provided by (used in) investing activities | 59,372 | (21,693) | |
Cash flows from financing activities | |||
Proceeds from debt | 60,164 | 66,318 | |
Repayment of debt | (60,125) | (43,598) | |
Repayment of finance lease obligations | (230) | (178) | |
Payment for tax withholding obligations for issuance of common | — | (2) | |
Distribution to noncontrolling interest | — | (64) | |
Net cash (used in) provided by financing activities | (191) | 22,476 | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 55 | 64 | |
Net increase in cash, cash equivalents and restricted cash | 35,781 | 15,532 | |
Cash, cash equivalents and restricted cash, beginning of period | 267,961 | 192,232 | |
Cash, cash equivalents and restricted cash, end of period | $ 303,742 | $ 207,764 | |
Non-cash transactions | |||
Property, plant and equipment purchases funded by liabilities | $ 11,322 | $ 31,948 | |
Right-of-use assets obtained in exchange for lease obligations | 6,283 | 1,257 |
The following table reconciles our cash and cash equivalents and restricted cash reported on our Condensed Consolidated Balance Sheets and the cash, cash equivalents and restricted cash reported on our Condensed Consolidated Statements of Cash Flows as of April 2, 2023 and April 3, 2022:
(In thousands) | April 2, 2023 | April 3, 2022 | |
Cash and cash equivalents | $ 278,849 | $ 176,679 | |
Restricted cash, current portion, included in Prepaid expenses and | 24,891 | 7,009 | |
Restricted cash, net of current portion, included in Other long-term | 2 | 24,076 | |
Total cash, cash equivalents and restricted cash shown in Condensed | $ 303,742 | $ 207,764 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/maxeon-solar-technologies-announces-first-quarter-2023-financial-results-301821035.html
SOURCE Maxeon Solar Technologies, Ltd.